by Dylan Housman
The Food and Drug Administration (FDA) issued a warning Monday that the Johnson & Johnson COVID-19 vaccine could be linked to a rare neurological condition called Guillain-Barré syndrome.
FDA regulators found that recipients of the J&J shot may be three-to-five times more likely to develop the disorder than the general population. A new warning has been added to fact sheets distributed to both vaccine recipients and healthcare providers by the agency.
[…] Regulators discovered about 100 suspected cases of Guillain-Barré, 95% of which required hospitalization, according to The New York Times. The agency said it cannot yet confirm that the relationship between the syndrome and the vaccine is “causal.”